{"log_id": 279698461542407719, "direction": 0, "words_result_num": 32, "words_result": [{"probability": {"variance": 0, "average": 0.997234, "min": 0.997234}, "location": {"width": 28, "top": 177, "height": 28, "left": 1176}, "words": "章"}, {"probability": {"variance": 0, "average": 0.999501, "min": 0.99873}, "location": {"width": 114, "top": 203, "height": 26, "left": 217}, "words": "【不良反应】"}, {"probability": {"variance": 0.001244, "average": 0.991127, "min": 0.760282}, "location": {"width": 811, "top": 243, "height": 37, "left": 231}, "words": "对765例接受单药治疗,使用推荐剂量350mg/m2的患者,及145例接受联合治疗,使用本品"}, {"probability": {"variance": 0.000982, "average": 0.991847, "min": 0.791823}, "location": {"width": 814, "top": 292, "height": 37, "left": 211}, "words": "推荐剂量180mg/m2,每2周给药一次,联合5-氟尿嘧啶/亚叶酸治疗的患者进行的研究表明"}, {"probability": {"variance": 2e-06, "average": 0.998929, "min": 0.995499}, "location": {"width": 319, "top": 346, "height": 30, "left": 212}, "words": "以下不良反应可能与使用本品有关"}, {"probability": {"variance": 3.9e-05, "average": 0.994457, "min": 0.98577}, "location": {"width": 106, "top": 396, "height": 27, "left": 212}, "words": "胃肠道病症"}, {"probability": {"variance": 0.001828, "average": 0.98895, "min": 0.760067}, "location": {"width": 636, "top": 439, "height": 34, "left": 211}, "words": "迟发性腹泻:腹泻(用药24小时后发生)是本品的剂量限制性毒性反应"}, {"probability": {"variance": 0.002098, "average": 0.989366, "min": 0.710581}, "location": {"width": 831, "top": 484, "height": 39, "left": 211}, "words": "在单药治疗中一一在所有听从腹泻处理措施忠告的患者中有20%发生严重腹泻。在可评估的"}, {"probability": {"variance": 7.6e-05, "average": 0.997559, "min": 0.948505}, "location": {"width": 740, "top": 536, "height": 34, "left": 212}, "words": "治疗周期内,14%出现严重腹泻。出现第一次稀便的中位时间为滴注本品后第5天"}, {"probability": {"variance": 0.007197, "average": 0.979164, "min": 0.46312}, "location": {"width": 832, "top": 583, "height": 35, "left": 211}, "words": "在联合治疗中一—在所有听从腹泻处理措施忠告的患者中有13.1%发生严重腹泻。在可评估"}, {"probability": {"variance": 8e-06, "average": 0.998343, "min": 0.988296}, "location": {"width": 330, "top": 636, "height": 32, "left": 211}, "words": "的治疗周期内,3.9%出现严重腹泻"}, {"probability": {"variance": 0.001165, "average": 0.988496, "min": 0.848027}, "location": {"width": 713, "top": 680, "height": 35, "left": 211}, "words": "有个别病例出现假膜性结肠炎,其中1例已被细菌学证实(难辨梭状芽孢杆菌)"}, {"probability": {"variance": 0.000113, "average": 0.996173, "min": 0.938183}, "location": {"width": 720, "top": 729, "height": 30, "left": 211}, "words": "恶心与呕吐:在单药治疗中一一使用止吐药后约10%患者发生严重的恶心及呕吐"}, {"probability": {"variance": 5.6e-05, "average": 0.99639, "min": 0.955507}, "location": {"width": 742, "top": 779, "height": 29, "left": 212}, "words": "在联合治疗中一一严重的恶心和呕吐发生率较低(分别为患者的2.1%和2.8%)。"}, {"probability": {"variance": 0.000485, "average": 0.991229, "min": 0.919956}, "location": {"width": 444, "top": 828, "height": 29, "left": 212}, "words": "脱水:与腹泻及/或呕吐相关的脱水症状已有报导"}, {"probability": {"variance": 0.000969, "average": 0.994264, "min": 0.802423}, "location": {"width": 808, "top": 875, "height": 31, "left": 212}, "words": "在与腹泻和/或呕吐有关的脱水患者中,肾功能不全、低血压或心脏及循环系统衰竭罕见"}, {"probability": {"variance": 0.000916, "average": 0.991491, "min": 0.830377}, "location": {"width": 595, "top": 924, "height": 31, "left": 212}, "words": "其他胃肠道病症:可发生与本品及/或氯苯哌酰胺治疗有关的便秘:"}, {"probability": {"variance": 2.3e-05, "average": 0.998024, "min": 0.978098}, "location": {"width": 384, "top": 973, "height": 30, "left": 212}, "words": "在单药治疗中一一有少于10%的患者发生"}, {"probability": {"variance": 0.000298, "average": 0.993968, "min": 0.925478}, "location": {"width": 352, "top": 1021, "height": 31, "left": 212}, "words": "在联合治疗中一一有3.4%的患者发生"}, {"probability": {"variance": 0.000243, "average": 0.993767, "min": 0.937455}, "location": {"width": 585, "top": 1068, "height": 32, "left": 212}, "words": "肠梗阻、肠塞绞痛或胃肠道出血罕见;大肠炎罕见;罕见肠穿孔"}, {"probability": {"variance": 0.000112, "average": 0.996742, "min": 0.954702}, "location": {"width": 353, "top": 1119, "height": 30, "left": 212}, "words": "其他轻微反应如:厌食,腹痛及粘膜炎"}, {"probability": {"variance": 0, "average": 0.999388, "min": 0.998471}, "location": {"width": 108, "top": 1170, "height": 26, "left": 213}, "words": "血液学病症"}, {"probability": {"variance": 2e-06, "average": 0.999185, "min": 0.994814}, "location": {"width": 342, "top": 1215, "height": 29, "left": 214}, "words": "中性粒细胞减少症是剂量限制性毒性"}, {"probability": {"variance": 0, "average": 0.943214, "min": 0.943214}, "location": {"width": 194, "top": 1198, "height": 40, "left": 761}, "words": "海"}, {"probability": {"variance": 0.000679, "average": 0.99199, "min": 0.867801}, "location": {"width": 826, "top": 1264, "height": 30, "left": 215}, "words": "中性粒细胞减少症是可逆转和非蓄积的;无论在单药治疗或联合治疗中,到最低点的中位时"}, {"probability": {"variance": 8.2e-05, "average": 0.99363, "min": 0.978142}, "location": {"width": 76, "top": 1318, "height": 24, "left": 215}, "words": "间为8天"}, {"probability": {"variance": 0.001814, "average": 0.989597, "min": 0.724614}, "location": {"width": 815, "top": 1363, "height": 29, "left": 214}, "words": "在单药治疗中一-78.7%的患者出现过中性粒细胞减少症,严重者(中性粒细胞计数小于"}, {"probability": {"variance": 0.013407, "average": 0.958791, "min": 0.415008}, "location": {"width": 822, "top": 1412, "height": 29, "left": 222}, "words": "00/mm3占22.6%。在可评价的治疗周期内,18%出现中性粒细胞计数<1000m,其中7.6"}, {"probability": {"variance": 7.8e-05, "average": 0.995121, "min": 0.958841}, "location": {"width": 531, "top": 1463, "height": 27, "left": 216}, "words": "%中性粒细胞计数<500/mm3。通常在第22天完全恢复正常"}, {"probability": {"variance": 2.9e-05, "average": 0.997369, "min": 0.973176}, "location": {"width": 828, "top": 1511, "height": 28, "left": 216}, "words": "62%的患者(1.7%的治疗周期),出现严重中性粒细胞减少症合并发热10.3%的患者(2.5"}, {"probability": {"variance": 0.001373, "average": 0.991203, "min": 0.753578}, "location": {"width": 826, "top": 1559, "height": 29, "left": 216}, "words": "%的治疗周期)出现感染:5.3%的患者(1.1%的治疗周期)出现严重中性粒细胞减少症合"}, {"probability": {"variance": 1.8e-05, "average": 0.998277, "min": 0.985401}, "location": {"width": 203, "top": 1609, "height": 26, "left": 216}, "words": "并感染,2例导致死亡"}], "language": 3}